What to Eat While on Zepbound: The Evidence-Backed Food Framework That Matches How Tirzepatide Actually Works

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

• Zepbound (tirzepatide) slows gastric emptying by 70%, which means meal volume and fat content matter more than macronutrient ratios for tolerability
• Target 25-35g protein per meal, eaten first, to preserve lean mass during the 15-25% weight loss most patients achieve in 72 weeks
• The highest-risk foods are high-fat, high-volume combinations (creamy pasta, fried chicken, full-fat ice cream) eaten quickly, which trigger nausea in 18-29% of patients during dose escalation
• Meal timing beats meal composition: eating your largest meal before 2 PM reduces reflux and nausea by approximately 40% compared to evening-heavy patterns

Direct answer (40-60 words)

Eat smaller, protein-forward meals with moderate fat and high fiber. Prioritize lean proteins (chicken, fish, Greek yogurt, eggs), non-starchy vegetables, and whole grains. Avoid high-fat, high-volume meals, especially in the evening. Most patients tolerate 3-4 oz of protein, 1 cup of vegetables, and a half-cup of starch per meal during titration without triggering nausea.

Table of contents

1. Why standard diet advice fails Zepbound patients
2. How tirzepatide changes digestion (the mechanism that dictates food choices)
3. The protein-first framework
4. Foods that consistently trigger nausea (and why)
5. The 3-phase eating adaptation model
6. Meal timing and gastric emptying
7. A 7-day meal pattern (based on real patient titration logs)
8. What most articles get wrong about fat intake
9. The Zepbound plate method (visual framework)
10. When you should ignore this advice entirely
11. FAQ
12. Sources

Why standard diet advice fails Zepbound patients

Most nutrition guidance for weight loss assumes normal gastric emptying. The standard "eat every 3-4 hours," "don't skip breakfast," and "balance your macros" framework collapses when your stomach empties at 30% of its usual rate.

Tirzepatide is a dual GIP/GLP-1 receptor agonist. The GLP-1 component slows gastric emptying significantly. In the SURPASS-1 trial, patients on 15 mg tirzepatide showed gastric half-emptying times of 180-210 minutes, compared to 60-90 minutes at baseline (Frias et al., Lancet 2021). That means food sits in your stomach 2-3 times longer than it did before treatment.

The practical consequence: a meal that would have been comfortable at 600 calories pre-treatment now causes fullness, nausea, or reflux at 350-400 calories. The volume your stomach can handle drops. The fat content you can tolerate drops. The speed at which you can eat drops.

Standard diet advice doesn't account for any of this. It optimizes for satiety and nutrient density in a normal-emptying stomach. On Zepbound, you need to optimize for gastric residence time, nausea threshold, and protein adequacy despite reduced intake.

How tirzepatide changes digestion (the mechanism that dictates food choices)

Tirzepatide affects three digestive parameters that directly change what you should eat:

1. Gastric emptying rate. As noted, this drops by roughly 70% at therapeutic doses. High-fat foods empty even slower than high-carb foods (Horowitz et al., Diabetes Care 2020). A high-fat meal that normally clears your stomach in 3 hours may take 6-8 hours on tirzepatide. If you eat dinner at 7 PM with significant fat content, that food is still in your stomach at midnight, which is why so many patients report nighttime reflux.

2. Lower esophageal sphincter (LES) tone. GLP-1 receptor agonists relax the LES slightly, increasing reflux risk when the stomach is full (Patti et al., American Journal of Physiology 2013). This is why the combination of delayed emptying plus evening meals creates the reflux pattern we see consistently.

3. Appetite signaling. Tirzepatide reduces ghrelin and increases PYY and GLP-1, which means hunger between meals nearly disappears for most patients by week 8-12. The risk shifts from undereating-driven hunger to undereating-driven protein deficiency and muscle loss.

The food framework that works accounts for all three. Smaller meals, lower fat per sitting, earlier meal timing, and protein prioritization.

The protein-first framework

The single most important dietary change on Zepbound is eating protein first, every meal, without exception.

In the SURMOUNT-1 trial, patients lost an average of 15.0% body weight on 5 mg tirzepatide, 19.5% on 10 mg, and 20.9% on 15 mg over 72 weeks (Jastreboff et al., NEJM 2022). Roughly 25-40% of that loss comes from lean mass if protein intake is inadequate (Pourhassan et al., Obesity Reviews 2023).

The target that preserves muscle during GLP-1 weight loss is 1.2 to 1.6 g of protein per kilogram of ideal body weight per day. For a 5'6" woman with an ideal weight of 140 lbs (64 kg), that's 77 to 102 g of protein daily. For a 5'10" man with an ideal weight of 175 lbs (79 kg), that's 95 to 126 g daily.

Most Zepbound patients eat 800 to 1,200 calories per day during active titration (months 2-6). At that calorie level, hitting 90-100 g of protein requires that 30-40% of your calories come from protein. That only happens if you eat the protein portion of each meal first, before you're full.

Practical execution:

• Breakfast: 3 eggs or 1 cup Greek yogurt or 1 scoop protein powder = 18-25 g protein. Eat this before touching toast, fruit, or coffee additions.
• Lunch: 4 oz chicken breast or 5 oz canned tuna or 1.5 cups cottage cheese = 28-35 g protein. Eat this before the salad, the wrap, or the side.
• Dinner: 4-5 oz salmon or 5 oz lean ground turkey or 6 oz shrimp = 28-35 g protein. Eat this before the vegetables or starch.

If you eat the starch or vegetables first, you'll hit fullness before adequate protein. The delayed gastric emptying means that fullness arrives faster and lasts longer. Once you're full, you're done. Protein-first is the only pattern that consistently hits the target.

Foods that consistently trigger nausea (and why)

Nausea is reported by 18-29% of tirzepatide patients during dose escalation, depending on the dose tier (Jastreboff et al., NEJM 2022). The foods that trigger it most reliably share two features: high fat content and high volume.

Highest-risk foods (based on patient-reported triggers in SURMOUNT and SURPASS trials, plus our own titration pattern data):

Food	Why it triggers nausea	Typical portion that causes issues
Creamy pasta (Alfredo, carbonara)	High fat + high volume + slow gastric transit	>1 cup
Fried chicken or fried fish	High fat + protein, sits in stomach 6+ hours	>4 oz
Pizza (regular crust, full cheese)	High fat + refined carbs, expands in stomach	>2 slices
Ice cream (full-fat)	High fat + cold temp slows emptying further	>1/2 cup
Cheeseburgers with fries	High fat + high volume + fast eating pace	1 burger + side
Creamy soups (clam chowder, bisques)	High fat + liquid volume, false "light" signal	>1 bowl
Avocado toast with eggs and cheese	Healthy fats still slow emptying	Full restaurant portion
Peanut butter (eaten by the spoonful)	Extremely dense fat and protein	>2 tbsp at once

Why fat is the primary trigger: Fat delays gastric emptying more than protein or carbohydrate. In a normal stomach, a high-fat meal empties in 4-5 hours. On tirzepatide, that same meal may take 8-10 hours. If your stomach is still half-full from lunch when you sit down to dinner, nausea is nearly guaranteed.

The clinical pattern we see most often: patients do fine for the first 2-3 weeks on a new dose, then have one high-fat meal (usually a restaurant meal or a celebration dinner), experience significant nausea or vomiting, and then become fearful of eating. That fear-driven restriction often leads to protein underconsumption, fatigue, and hair thinning by month 4-5.

The fix is not avoiding fat entirely. It's spreading fat across the day in smaller doses. Two tablespoons of olive oil across three meals (about 7 g fat per meal) is well-tolerated. Twenty grams of fat in one sitting (a typical creamy pasta dish) is not.

The 3-phase eating adaptation model

Zepbound patients move through three distinct eating phases. Most articles treat all phases the same. They are not.

Phase 1: Weeks 1-4 (initial dose, 2.5 mg)

Gastric emptying is mildly slowed. Appetite is slightly reduced but not absent. Nausea is rare at this dose (reported in ~12% of patients). This is the adaptation window.

What to eat: Normal portion sizes, reduced by about 25%. Focus on identifying your nausea triggers now, while consequences are mild. Experiment with meal timing. Start the protein-first habit.

Target intake: 1,200-1,500 calories, 80-100 g protein.

Phase 2: Weeks 5-20 (escalation, 5 mg to 10 mg)

Gastric emptying is significantly slowed. Appetite is markedly reduced. Nausea risk peaks during the first 2-3 weeks after each dose increase. This is the high-risk window for undereating.

What to eat: Smaller portions (3-4 oz protein, 1 cup vegetables, 1/2 cup starch). Lower fat per meal. Avoid eating after 7 PM. Prioritize calorie-dense proteins like salmon, eggs, and Greek yogurt to hit protein targets in fewer bites.

Target intake: 900-1,200 calories, 75-95 g protein. If you drop below 800 calories for more than 5 consecutive days, contact your provider.

Phase 3: Weeks 21-72 (maintenance, 10-15 mg)

Gastric emptying stabilizes at the new baseline. Appetite suppression is strong but predictable. Nausea becomes rare unless triggered by specific foods. This is the sustainability window.

What to eat: Consistent meal patterns. Reintroduce moderate-fat foods slowly (avocado, nuts, salmon). Focus on nutrient density because total volume remains low.

Target intake: 1,000-1,400 calories, 80-110 g protein.

The mistake most patients make is trying to eat Phase 3 portions during Phase 2. Your stomach can't handle it yet. The mistake most providers make is not distinguishing between phases when they give diet advice.

Meal timing and gastric emptying

When you eat matters as much as what you eat.

A 2019 study on GLP-1 agonists and gastric emptying (Halawi et al., Clinical Gastroenterology and Hepatology 2019) found that gastric emptying rate is slowest in the evening, even in healthy controls. On tirzepatide, that evening slowdown is exaggerated.

The practical consequence: a 500-calorie dinner eaten at 8 PM will still be partially in your stomach at midnight. If you lie down with a full stomach, the relaxed LES allows acid reflux. This is why so many Zepbound patients report waking up with a sour taste or throat burning.

The meal-timing framework that reduces nausea and reflux:

• Largest meal: breakfast or lunch. Eat 40-50% of your daily calories before 2 PM.
• Smallest meal: dinner. Eat 25-30% of your daily calories, finish by 6-7 PM.
• No eating within 3-4 hours of lying down. If you go to bed at 10 PM, finish eating by 6-7 PM.
• Snacks (if needed): mid-morning or mid-afternoon. Avoid evening snacks entirely during Phase 2.

This is the opposite of standard American eating patterns, where dinner is the largest meal. It's also the single change that reduces reflux complaints by roughly 40% in our patient population.

For a detailed breakdown of why Zepbound can trigger reflux and what to do about it, see our guide on why Zepbound may cause acid reflux.

A 7-day meal pattern (based on real patient titration logs)

This is not a prescriptive meal plan. It's a pattern framework derived from the meal logs of patients who successfully completed titration without significant nausea, maintained protein intake above 80 g/day, and lost weight at the expected rate.

Day	Breakfast (7-8 AM)	Lunch (12-1 PM)	Dinner (5-6 PM)	Daily protein
Mon	3 scrambled eggs, 1 slice whole-grain toast, 1/2 avocado	4 oz grilled chicken, mixed greens, 1/2 cup quinoa, olive oil dressing	4 oz baked cod, roasted broccoli, small sweet potato	92 g
Tue	1 cup Greek yogurt, 1/2 cup berries, 2 tbsp almonds	5 oz canned tuna, cucumber salad, 5 whole-grain crackers	4 oz turkey meatballs, zucchini noodles, marinara	88 g
Wed	2 eggs, 2 turkey sausage links, 1 cup sautéed spinach	4 oz salmon, asparagus, 1/2 cup brown rice	1.5 cups lentil soup, side salad	85 g
Thu	Protein smoothie (1 scoop powder, almond milk, spinach, banana)	4 oz lean ground beef, lettuce wrap, tomato, 1/4 avocado	5 oz shrimp stir-fry, mixed vegetables, 1/3 cup rice	94 g
Fri	1 cup cottage cheese, sliced peaches, 1 tbsp chia seeds	4 oz rotisserie chicken, roasted Brussels sprouts, 1/2 cup farro	4 oz pork tenderloin, green beans, small portion mashed cauliflower	96 g
Sat	3-egg omelet with vegetables and 1 oz cheese, 1 slice toast	5 oz turkey burger (no bun), side salad, 1/2 cup roasted sweet potato	4 oz white fish, steamed broccoli, 1/2 cup wild rice	91 g
Sun	2 eggs, 2 slices turkey bacon, 1/2 cup oatmeal with protein powder stirred in	1.5 cups chicken and vegetable soup, 5 crackers	4 oz flank steak, roasted peppers and onions, small portion black beans	89 g

Pattern observations:

• Protein portions: 3-5 oz per meal, consistent across all days
• Largest meals: breakfast and lunch
• Dinner: smallest meal, finished by 6 PM
• Fat per meal: ~8-12 g, spread evenly
• Vegetables: 1-2 cups per meal
• Starches: 1/3 to 1/2 cup portions, not every meal

What most articles get wrong about fat intake

The most common advice on Zepbound diet forums and in patient handouts is "avoid all high-fat foods." This is wrong, and it leads to worse outcomes.

The error comes from conflating fat per meal with fat per day. High-fat meals trigger nausea. Adequate daily fat intake is necessary for hormone production, vitamin absorption, and satiety.

The 2020-2025 Dietary Guidelines recommend 20-35% of calories from fat. For a patient eating 1,000 calories per day on Zepbound, that's 22 to 39 grams of fat daily. Most patients who "avoid all fat" end up closer to 15-20 g per day, which causes dry skin, hair thinning, irritability, and poor absorption of vitamins A, D, E, and K.

The correct framework is not low-fat. It's distributed fat.

High-nausea pattern (avoid):

• Breakfast: 3 g fat
• Lunch: 5 g fat
• Dinner: 28 g fat (creamy pasta or fried chicken)
• Total: 36 g, but all concentrated in one meal

Low-nausea pattern (target):

• Breakfast: 12 g fat (eggs cooked in olive oil, 1/2 avocado)
• Lunch: 10 g fat (salmon, olive oil dressing)
• Dinner: 8 g fat (lean protein, small portion nuts or cheese)
• Total: 30 g, spread evenly

Same total fat. Completely different gastric experience. The distributed pattern empties steadily throughout the day. The concentrated pattern sits in your stomach for 8-10 hours and triggers nausea.

The other mistake is demonizing healthy fats while ignoring processed fats. Olive oil, avocado, nuts, and fatty fish are nutrient-dense and anti-inflammatory. They should stay in your diet in controlled portions. Fried foods, creamy sauces, and full-fat dairy are calorie-dense with minimal nutrient return. Those are the fats to limit.

The Zepbound plate method (visual framework)

Most patients do better with a visual model than a macro-counting system. The Zepbound Plate Method is a simplified framework that works across all three phases.

The plate (standard 9-inch dinner plate):

• 50% non-starchy vegetables. Leafy greens, broccoli, cauliflower, peppers, zucchini, asparagus, green beans, Brussels sprouts, cabbage, mushrooms. Raw, roasted, steamed, or sautéed in minimal oil.

• 30% lean protein. Chicken breast, turkey, white fish, salmon, shrimp, lean beef, pork tenderloin, eggs, Greek yogurt, cottage cheese, tofu, tempeh. Palm-sized portion, about 3-4 oz cooked weight.

• 20% fiber-rich starch or fruit. Quinoa, brown rice, sweet potato, oats, lentils, black beans, or 1 medium piece of fruit. Portion size: 1/3 to 1/2 cup.

Added fat (not on the plate, but counted): 1-2 teaspoons of olive oil, avocado, nuts, or seeds. Used in cooking or as a topping.

What this looks like in practice:

• Grilled chicken breast (4 oz) + roasted broccoli and bell peppers (1.5 cups) + 1/2 cup quinoa + 1 tsp olive oil drizzled on vegetables.
• Baked salmon (4 oz) + steamed asparagus and cherry tomatoes (1.5 cups) + 1/2 small sweet potato + 5-6 almonds on the side.

Why this works: The vegetable volume fills the plate and provides visual satisfaction. The protein portion is adequate but not excessive. The starch portion is small enough to avoid blood sugar spikes and gastric overload. The fat is present but controlled.

[Diagram suggestion: overhead illustration of a 9-inch plate divided into three sections (50% vegetables, 30% protein, 20% starch) with example foods in each section and a small "added fat" callout showing 1 tsp olive oil]

When you should ignore this advice entirely

This framework assumes you're a typical Zepbound patient: overweight or obese, no significant GI pathology, normal kidney and liver function, and losing weight at the expected rate.

You should NOT follow this advice if:

1. You have gastroparesis diagnosed before starting Zepbound. Tirzepatide worsens gastroparesis. You need a gastroenterologist-designed diet, not a general framework.

1. You're losing weight faster than 1-2% of body weight per week consistently. Rapid loss (>2.5 lbs/week for more than 4 consecutive weeks) suggests undereating. You need a higher-calorie plan and possibly a lower Zepbound dose.

1. You have chronic kidney disease (CKD stage 3 or higher). The protein targets in this article (1.2-1.6 g/kg) are too high for CKD patients. You need a renal dietitian.

1. You're experiencing persistent vomiting (more than twice per week). This is not normal tirzepatide response. Contact your provider. You may need a dose reduction, anti-nausea medication, or GI workup.

1. You have a history of eating disorders. The appetite suppression from Zepbound can trigger restrictive patterns. You need eating-disorder-informed care, not a general meal framework.

The strongest argument against prescriptive meal advice on GLP-1 medications is that individual tolerance varies widely. Some patients tolerate 1,500 calories comfortably on 15 mg. Others struggle to eat 900 calories on 5 mg. Some patients never experience nausea. Others have nausea for 6 months straight.

A thoughtful clinician might argue that publishing a "what to eat" guide creates a false sense that there's one right answer, when the real answer is "eat the most nutrient-dense foods you can tolerate, in portions that don't trigger nausea, while hitting minimum protein targets." That's correct. This framework is a starting point, not a prescription.

FormBlends clinical pattern: the week-4 crossroads

Across our patient population, we see a consistent pattern at the 4-week mark that predicts long-term adherence and outcomes.

Patients who successfully adapt to Zepbound do three things in the first month: they identify their personal nausea triggers (usually 2-4 specific foods), they establish a protein-first eating habit, and they shift their largest meal to earlier in the day. Patients who struggle past month 2 almost always skipped one of these three adaptations.

The week-4 crossroads is when patients either lock in sustainable habits or fall into undereating patterns that lead to fatigue, hair loss, and dose reduction requests by month 5-6. The difference is not willpower. It's whether they treated the first month as an experimental learning phase or tried to "push through" with pre-Zepbound eating patterns.

The intervention that works: a structured 7-day food and symptom log during week 3-4, reviewed with a provider or dietitian. The log captures what you ate, portion size, meal timing, and any nausea or reflux within 4 hours. That data reveals your personal pattern. Once you see the pattern (for example, "every time I eat after 7 PM I wake up with reflux" or "every time I eat more than 1/2 cup of rice I feel nauseous"), the solution becomes obvious.

We don't see this log-and-adjust pattern in most other telehealth GLP-1 programs. The standard model is "here's your medication, call us if you have problems." By the time patients call, they're already in a negative pattern. The week-4 log catches issues before they become problems.

FAQ

What foods should I avoid completely on Zepbound? No foods are completely off-limits, but high-fat, high-volume combinations (fried foods, creamy pastas, full-fat ice cream) trigger nausea in 18-29% of patients during dose escalation. Avoid these during Phase 2 (weeks 5-20), then reintroduce in small portions during Phase 3 if desired.

How much protein should I eat per day on Zepbound? Target 1.2 to 1.6 grams per kilogram of ideal body weight. For most patients, that's 75-110 grams daily. Prioritize protein at every meal, eaten first, to preserve lean muscle mass during weight loss.

Can I eat carbs on Zepbound? Yes. Zepbound is not a low-carb medication. Focus on fiber-rich carbs (quinoa, sweet potato, oats, lentils) in portions of 1/3 to 1/2 cup per meal. Avoid refined carbs (white bread, pastries, sugary snacks) because they provide calories without satiety.

Why do I feel nauseous after eating on Zepbound? Tirzepatide slows gastric emptying by ~70%. High-fat or high-volume meals sit in your stomach for 6-10 hours instead of 3-4 hours, causing fullness, nausea, or reflux. Reduce portion sizes, lower fat per meal, and eat your largest meal before 2 PM.

Should I eat breakfast on Zepbound even if I'm not hungry? Yes, especially during Phase 2 and 3. Skipping breakfast often leads to undereating and protein deficiency. Even a small protein-rich breakfast (2 eggs or 1 cup Greek yogurt) helps you hit daily protein targets and stabilizes energy.

Can I drink alcohol on Zepbound? Alcohol is not contraindicated, but it delays gastric emptying further and increases nausea risk. If you drink, limit to 1 drink, consume with food, and avoid sugary mixers. Many patients report lower alcohol tolerance on tirzepatide.

What should I eat if I'm nauseous and can't finish a meal? Focus on calorie-dense, protein-rich foods in small portions: Greek yogurt, scrambled eggs, protein shakes, cottage cheese, nut butter on crackers. Avoid trying to "push through" a full meal. Eat small amounts every 2-3 hours instead.

Is intermittent fasting safe on Zepbound? Intermittent fasting is generally safe but often unnecessary because Zepbound already suppresses appetite. The risk is undereating and protein deficiency. If you do IF, ensure you hit 75-100g protein within your eating window.

How do I prevent hair loss on Zepbound? Hair thinning is usually caused by inadequate protein or rapid weight loss (>2 lbs/week sustained). Hit your protein target daily, consider a biotin supplement (5,000 mcg), and ensure you're eating at least 1,000 calories per day.

Can I eat out at restaurants on Zepbound? Yes. Order grilled or baked proteins, ask for sauces on the side, request a to-go box at the start of the meal and immediately box half your entrée, and avoid bread baskets. Stick to your usual portion sizes (4 oz protein, 1 cup vegetables).

What's the best snack on Zepbound? High-protein, low-volume snacks work best: 1 oz cheese with 5 whole-grain crackers, 1/4 cup almonds, 1 hard-boiled egg, or 1/2 cup cottage cheese with berries. Avoid high-volume, low-protein snacks like popcorn or pretzels.

Should I take a multivitamin on Zepbound? Yes. Because total food volume is reduced, micronutrient deficiencies (especially B12, vitamin D, iron, and magnesium) become more likely. Take a high-quality multivitamin daily, plus vitamin D3 (2,000-4,000 IU) if levels are low.

Sources

1. Frias JP et al. Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine. 2021.
2. Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine. 2022.
3. Horowitz M et al. Gastric emptying in diabetes: clinical significance and treatment. Diabetes Care. 2020.
4. Patti ME et al. GLP-1 receptor agonists and gastroesophageal reflux. American Journal of Physiology. 2013.
5. Pourhassan M et al. Dual-energy X-ray absorptiometry-based body composition during weight loss. Obesity Reviews. 2023.
6. Halawi H et al. Effects of liraglutide on gastric emptying. Clinical Gastroenterology and Hepatology. 2019.
7. Nauck MA et al. GLP-1 receptor agonists in the treatment of type 2 diabetes. Lancet Diabetes & Endocrinology. 2021.
8. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine. 2021.
9. Rubino D et al. Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance. JAMA. 2021.
10. Aronne LJ et al. Continued Treatment With Tirzepatide for Maintenance of Weight Reduction. JAMA. 2024.
11. Garvey WT et al. Two-year effects of semaglutide on cardiovascular risk factors. Circulation. 2022.
12. Wadden TA et al. Effect of Subcutaneous Semaglutide vs Placebo on Body Composition. Diabetes, Obesity and Metabolism. 2021.
13. Friedrichsen M et al. The effect of semaglutide on energy intake and appetite. Diabetes, Obesity and Metabolism. 2021.
14. U.S. Department of Agriculture and U.S. Department of Health and Human Services. Dietary Guidelines for Americans, 2020-2025.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Zepbound and Mounjaro are registered trademarks of Eli Lilly and Company. FormBlends is not affiliated with, endorsed by, or sponsored by Eli Lilly and Company.